Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-01-19-Speech-3-217-250"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110119.20.3-217-250"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"This proposal clarifies and facilitates access to cross-border healthcare and the exercise of the right to reimbursement by the Member State of affiliation, enabling all patients in the EU to benefit from healthcare in other Member States. In fact, these rights were already recognised by the Court of Justice of the European Union. It is a step forward in the European integration process and in strengthening solidarity, with reduced waiting lists, improved quality of healthcare and an incentive towards scientific research. Rare diseases are a priority, and diagnosis and treatment can now be carried out in the Member State most suited to that end. This directive is for all Europeans who need healthcare. The Portuguese Minister for Health is therefore quite wrong when she says that this option is for better educated people and those with greater financial resources: that is what happens now, without the directive. Portugal has excellent healthcare and cannot remain on the sidelines of this important project: the country must take advantage of this directive to modernise even further and must compete in terms of being able to provide services in this area to all Europeans in need of them."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples